The 19th China (Chongqing) Senior Citizen Expo concludes successfully
CHONGQING, China, Nov. 13, 2025 /PRNewswire/ -- The 19th China (Chongqing) Senior Citizen Expo and the 1st Western International Conference on High-quality Development of Silver Economy, and the 6th China (Chongqing) Health Industry Expo (hereinafter referred to as the "Senior Citizen Expo") were successfully held at the Chongqing International Expo Center from November 7 to 9, 2025, guided by the China...
LISCure Expands Global Partnerships for BBB Shuttle Platform ‘ExoPN-101’; Signs Fourth MTA with Leading Pharma Partner
SEOUL, South Korea, Nov. 13, 2025 /PRNewswire/ -- LISCure Biosciences ("LISCure"), a biotechnology company advancing next-generation therapeutics, today announced that it has entered into a new Material Transfer Agreement (MTA) with a leading global pharmaceutical company for its proprietary blood-brain barrier (BBB) shuttle platform, ExoPN-101. This marks LISCure's fourth MTA, further validating...
HKSH Medical Group Hosts Hong Kong’s First Asia-Oceania Particle Therapy Co-operative Group Conference
Uniting Global Proton Therapy Leaders to Advance Precision Cancer Treatment HONG KONG, Nov. 13, 2025 /PRNewswire/ -- Hosted by The Li Shu Fan Medical Foundation and HKSH Medical Group (HKSH), and organised by the Asia-Oceania Particle Therapy Co-operative Group (PTCOG-AO), the 5th Annual Conference of the Asia-Oceania Particle Therapy Co-operative Group (PTCOG-AO 2025 Conference) was successfully held from 7 to 9 November...
Clarivate Companies to Watch Report Spotlights Seven Women’s Health Startups Shaping the Future of Care
Report highlights emerging biotech innovators advancing new therapies, equity and investment across reproductive, chronic and mental health LONDON, Nov. 13, 2025 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today released its latest Companies to Watch report, Rediscovering Women's Health, highlighting seven companies driving innovation across reproductive...
Project ACTIVE 2.0 Strengthens Global Collaboration to Advance Cervical Cancer Care in Southeast Asia
CHIANG MAI, Thailand, Nov. 13, 2025 /PRNewswire/ -- A major step forward in regional collaboration for cancer care was announced today with the launch of Project ACTIVE 2.0 (Advancing Cervical Cancer Treatment & Patient Recovery Across Southeast Asia), a multi-country initiative that aims to strengthen radiation oncology services and improve outcomes for cervical cancer across Southeast Asia. ...
KHB Showcases the Enhanced FOCUS PEGASUS MF200 — Redefining Efficiency in Veterinary Diagnostics
XI'AN, China, Nov. 13, 2025 /PRNewswire/ -- Guangzhou Focus Biotechnology Co., Ltd., a subsidiary of KHB Group and an innovator in veterinary point-of-care testing (POCT) solutions, presents the enhanced FOCUS PEGASUS MF200 Automatic Multifunctional Veterinary Analyzer — a next-generation system that redefines efficiency, reliability, and accessibility in veterinary diagnostics. The MF200 integrates...
Travelers from Singapore Can Now Access 24/7 Multilingual Online Doctor Consultations in Japan — M3 Career’s HOTEL de DOCTOR 24 Provides Peace of Mind During Unexpected Illness
TOKYO, Nov. 13, 2025 /PRNewswire/ -- HOTEL de DOCTOR 24, a specialized online medical consultation service provided by M3 Career, Inc., offers seamless 24-hour access to healthcare for international travelers facing difficulties obtaining medical care in Japan. While HOTEL de DOCTOR 24 has been available in Japan since April 2025 -- and already used by travelers from Singapore...
Robert Lewandowski Named Global Brand Ambassador for KSM-66 Ashwagandha
FC Barcelona Striker Partners with Most Clinically Researched Ashwagandha Brand, KSM-66 LOS ANGELES, Nov. 13, 2025 /PRNewswire/ -- KSM-66®, one of the world's largest natural product ingredient brands and best-selling ashwagandha extract, today announced Robert Lewandowski as its global brand ambassador. The FC Barcelona striker and Poland captain will represent the brand...
Agilent and National Heart Centre Singapore Sign Agreement to Advance Metabolic Heart Failure Research
Research focuses on human cardiac organoids to uncover metabolic drivers of heart failure and accelerate new therapeutic strategies to improve cardiovascular outcomes SINGAPORE, Nov. 13, 2025 /PRNewswire/ -- Agilent Technologies Inc. (NYSE: A) announced the signing of a five-year Memorandum of Understanding (MOU) with National Heart Centre Singapore (NHCS) to accelerate innovation in metabolic heart failure research, one of the most...
Medical AI Company VUNO Reports Profit in Q3, Driven by DeepCARS Growth
- 11 Consecutive Quarters of Revenue Growth; Q3 Revenue Exceeds KRW 10 billion for the First Time SEOUL, South Korea, Nov. 13, 2025 /PRNewswire/ -- VUNO Inc., a global medical AI company, announced that it was profitable in the third quarter of 2025, recording consolidated revenue of KRW 10.8 billion, operating profit of KRW 1.0 billion, and net profit...
